Cryptococcal meningitis in HIV (AIDS) patients: A Mini Review
Keywords:
Cryptococcal meningitis, HIV-associated
Abstract
Meningitis is a major health problem causing inflammation of the protective membranes covering the brain and spinal cord, collectively known as the meninges. Meningitis is generally caused by Meningococcus, Streptococcus pyogenes bacterial species causing bacterial meningitis: BM), Mycobacterium tuberculosis (Tubercular meningitis: TBM), Cryptococcus neoformans (fungal meningitis: CM). In recent times the CM and TBM are two most common types of chronic infectious meningitis. In adults, HIV-associated Cryptococcal meningitis has been reported in many areas of the world having high HIV seroprevalence i.e. in Sub-Saharan Africa. Cryptococcal meningitis is the fourth most commonly recognized cause of life-threatening infection among AIDS patients.Despite availability of antiretroviral therapy, the rise in rate of infections due to HIV/AIDS, suppress the cell mediated immune system and subjects are predisposed for opportunistic infections. Additionally, In AIDS patients, it is characterized by lack of meningeal signs and diminished inflammatory response. Diagnosis of CM is generally based on the collection of CSF sample and/or blood samples. Initially the CSF samples are processed for ‘gold standard’ culture methods, microscopy and India ink preparation. Serologically, Latex agglutination test (LAT) is the most commonly used for detection of Cryptococcal capsular antigen. Enzyme immunoassay (EIA) is another serological tool for detection of capsular polysaccharide antigens of C. neoformans in CSF.DOI: 10.21276/AABS.2017.1344References
[1] Sáez-Llorens X, McCracken GH. Bacterial meningitis in children.Lancet2003; 361:2139-2148.
[2] Qu J, Zhou T, Zhong C, Deng R, Lü X. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study.BMC infectious disease2017; 17:51.
[3] Williamson PR, Jarvis JN, Panackal AA, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.Nature reviews Neurology2017; 13:13-24.
[4] Britz E, Perovic O, von Mollendorf C, et al. The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012.PloS one2016; 11:e0163036.
[5] Banerjee U, Gupta K, Chatterjee B, Sethi S. Cryptococcosis at AIIMS.The National medical journal of India1994; 7:51-52.
[6] Banerjee U, Datta K, Majumdar T, Gupta K. Cryptococcosis in India: the awakening of a giant?Medical mycology2001; 39:51-67.
[7] Sharma SR, Hussain M, Habung H. Neurological manifestations of HIV-AIDS at a tertiary care institute in North Eastern India.Neurology India2017; 65:64-68.
[8] Indira P, Kumar PM, Shalini S, Vaman K. Opportunistic Infections among People Living with HIV (PLHIV) with Diabetes Mellitus (DM) Attending a Tertiary Care Hospital in Coastal City of South India.PloS one2015; 10:e0136280.
[9] Kwon-Drung KJ, Bennette JE, editors, Medical mycology.London: Lea and Febiger, 1992.
[10] Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.The New England journal of medicine1989; 32:794-799.
[11] Coen M, O'Sullivan M, Bubb WA, Kuchel PW, Sorrell T. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis.Clinical infectious disease2005; 41:1582-1590.
[12] Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum Cryptococcal Antigen in Patients with AIDS.Clinical infectious disease1996; 23:827-830.
[13] Casadevall A, Mukherjee J, Scharff MD. Monoclonal antibody based ELISAs for cryptococcal polysaccharide.Journal of immunological methods1992; 154:27-35.
[14] Sekhon AS, Garg AK, Kaufman L, Kobayashi GS, Hamir Z JM, Moledina N.Evaluation of a commercial enzyme immunoassay for the detection of cryptococcal antigen.Mycoses1993; 36:31-34.
[2] Qu J, Zhou T, Zhong C, Deng R, Lü X. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study.BMC infectious disease2017; 17:51.
[3] Williamson PR, Jarvis JN, Panackal AA, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.Nature reviews Neurology2017; 13:13-24.
[4] Britz E, Perovic O, von Mollendorf C, et al. The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012.PloS one2016; 11:e0163036.
[5] Banerjee U, Gupta K, Chatterjee B, Sethi S. Cryptococcosis at AIIMS.The National medical journal of India1994; 7:51-52.
[6] Banerjee U, Datta K, Majumdar T, Gupta K. Cryptococcosis in India: the awakening of a giant?Medical mycology2001; 39:51-67.
[7] Sharma SR, Hussain M, Habung H. Neurological manifestations of HIV-AIDS at a tertiary care institute in North Eastern India.Neurology India2017; 65:64-68.
[8] Indira P, Kumar PM, Shalini S, Vaman K. Opportunistic Infections among People Living with HIV (PLHIV) with Diabetes Mellitus (DM) Attending a Tertiary Care Hospital in Coastal City of South India.PloS one2015; 10:e0136280.
[9] Kwon-Drung KJ, Bennette JE, editors, Medical mycology.London: Lea and Febiger, 1992.
[10] Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.The New England journal of medicine1989; 32:794-799.
[11] Coen M, O'Sullivan M, Bubb WA, Kuchel PW, Sorrell T. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis.Clinical infectious disease2005; 41:1582-1590.
[12] Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum Cryptococcal Antigen in Patients with AIDS.Clinical infectious disease1996; 23:827-830.
[13] Casadevall A, Mukherjee J, Scharff MD. Monoclonal antibody based ELISAs for cryptococcal polysaccharide.Journal of immunological methods1992; 154:27-35.
[14] Sekhon AS, Garg AK, Kaufman L, Kobayashi GS, Hamir Z JM, Moledina N.Evaluation of a commercial enzyme immunoassay for the detection of cryptococcal antigen.Mycoses1993; 36:31-34.
Published
2017-02-28
Issue
Section
Review Articles
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).